N-Acetyl Carnosine
Evidence: MixedUseful mainly for people with early age-related cataract trialing it topically, with low expectations.
Quick decision guide
May help most
people with early age-related cataract trialing it topically, with low expectations
Common dosing range
1% ophthalmic drops, 1–2 drops per eye twice daily (topical formulations)
When to expect effects
Months if any
Watch out for
Evidence is weak and contested; it is not a substitute for cataract surgery or an eye exam
What is it
N-acetyl-carnosine (NAC, not to be confused with N-acetylcysteine) is an acetylated form of the dipeptide carnosine that resists breakdown by the enzyme carnosinase. It is used almost exclusively as a lubricant eye drop, marketed to slow or reverse age-related cataracts by acting as an antioxidant in the lens; oral use has essentially no clinical support. It serves in the eye as a prodrug that releases L-carnosine.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Evidence | Effect | Best fit | Time |
|---|---|---|---|---|
| age-related cataract | Mixed Evidence | Uncertain; small or none | adults with early, mild age-related cataract using topical drops | Months |
Evidence for 1 use
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
age-related cataract
Disease adjunctA few small studies, mostly from a single research group, reported improvements in lens clarity and visual acuity with topical N-acetyl-carnosine drops, but these have not been independently replicated and reviews judge the evidence as weak and at high risk of bias. Major eye-care bodies do not endorse it, and there is no credible evidence that oral supplementation affects cataracts.
Bottom line: Claims for cataract benefit rest on weak, unreplicated topical studies and should be treated skeptically.
Evidence is mixed
Early positive trials from one group conflict with the absence of independent replication and critical systematic reviews.
How to take it
- Typical dose
- 1% N-acetyl-carnosine ophthalmic drops, typically twice daily
- Timing
- morning and evening
- With food
- not applicable (topical)
- How long to try
- several months to assess any change
What to track
- visual acuity at eye exams
- glare and contrast sensitivity
- eye irritation or redness
Safety
Common side effects
transient eye stinging or blurring (topical)
Who should avoid it
- people relying on it instead of needed cataract surgery
Pregnancy & breastfeeding
No safety data; avoid unless advised by a clinician.
Choosing a product
Look for
- clearly labeled ophthalmic-grade 1% formulation if used as drops
- sterile, preservative details disclosed
- reputable manufacturer
Be skeptical of
- 'reverses cataracts' or 'avoids surgery' claims
- oral formulations promising eye benefits
- anti-aging cure-all marketing
References by claim
Track N-Acetyl Carnosine with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.